Molecular physiology of P2X receptors

RA North - Physiological reviews, 2002 - journals.physiology.org
P2X receptors are membrane ion channels that open in response to the binding of
extracellular ATP. Seven genes in vertebrates encode P2X receptor subunits, which are 40 …

International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors

BB Fredholm, AP IJzerman, KA Jacobson… - Pharmacological …, 2001 - ASPET
Four adenosine receptors have been cloned and characterized from several mammalian
species. The receptors are named adenosine A1, A2A, A2B, and A3. The A2A and A2B …

Xenobiotic, bile acid, and cholesterol transporters: function and regulation

CD Klaassen, LM Aleksunes - Pharmacological reviews, 2010 - ASPET
Transporters influence the disposition of chemicals within the body by participating in
absorption, distribution, and elimination. Transporters of the solute carrier family (SLC) …

The equilibrative nucleoside transporter family, SLC29

SA Baldwin, PR Beal, SYM Yao, AE King, CE Cass… - Pflügers Archiv, 2004 - Springer
The human SLC29 family of proteins contains four members, designated equilibrative
nucleoside transporters (ENTs) because of the properties of the first-characterised family …

Adenosine and sleep–wake regulation

R Basheer, RE Strecker, MM Thakkar… - Progress in …, 2004 - Elsevier
This review addresses three principal questions about adenosine and sleep–wake
regulation:(1) Is adenosine an endogenous sleep factor?(2) Are there specific brain regions …

Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression

EJ Carrier, JA Auchampach… - Proceedings of the …, 2006 - National Acad Sciences
The plant-derived cannabinoids Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD)
both have immunosuppressive effects; although some effects of THC are mediated by the …

Molecular and cellular mechanisms of chemoresistance in pancreatic cancer

A Adamska, O Elaskalani, A Emmanouilidi… - Advances in biological …, 2018 - Elsevier
Abstract Pancreatic Ductal Adenocarcinoma (PDAC) is one of the most chemoresistant
cancers, and current therapies targeting cancer-associated molecular pathways have not …

Nucleoside analogues: mechanisms of drug resistance and reversal strategies

CM Galmarini, JR Mackey, C Dumontet - Leukemia, 2001 - nature.com
Nucleoside analogues (NA) are essential components of AML induction therapy (cytosine
arabinoside), effective treatments of lymphoproliferative disorders (fludarabine, cladribine) …

Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer

JJ Farrell, H Elsaleh, M Garcia, R Lai, A Ammar… - Gastroenterology, 2009 - Elsevier
BACKGROUND & AIMS: The human equilibrative nucleoside transporter (hENT1) protein
transports gemcitabine into cells. Small retrospective studies in pancreatic cancer suggest …

The absence of human equilibrative nucleoside transporter 1 is associated with reduced survival in patients with gemcitabine-treated pancreas adenocarcinoma

J Spratlin, R Sangha, D Glubrecht, L Dabbagh… - Clinical Cancer …, 2004 - AACR
Purpose: Gemcitabine monotherapy is the standard palliative chemotherapy for pancreatic
adenocarcinoma. Gemcitabine requires plasma membrane nucleoside transporter proteins …